Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph C Galante is Director at Cumberland Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Mar 20, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Joseph C Galante bought shares on the open market in 2018, 2019, 2020, 2021 and 2022, and has not bought since 2022.
Joseph C Galante reported 455 open-market purchases and 0 sales since 2018; purchases in 5 different years, most recently 2022.
| Year | Bought | Sold |
|---|---|---|
| 2022 | $29K171×171 trades | — |
| 2021 | $34K83×83 trades | — |
| 2020 | $36K87×87 trades | — |
| 2019 | $48K113×113 trades | — |
| 2018 | $1.5K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Cumberland PharmaceuticalsCPIX
Mar 18, 20261,800disclosed Mar 20
DetailsOfficial recordAs of the latest filing on , Joseph C Galante reported holding 63,656 shares of Cumberland Pharmaceuticals (CPIX), worth about $369K at the last close of $6 (Nov 17, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals CPIX | 63,656 | 64K direct | $6 | $369K | Mar 18, 2026 |
Is this Joseph C Galante’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Mar 18, 2026, Joseph C Galante reported holding 63,656 shares of Cumberland Pharmaceuticals (CPIX). At the last close of $6 on Nov 17, 2026, that is about $369K. This is the stake disclosed in filings, not a net worth.
Joseph C Galante bought shares on the open market in 2018, 2019, 2020, 2021 and 2022, and has not bought since 2022.
In SEC filings since 2018: the latest open-market purchase is from 2022; no open-market sale is on record.
Cumberland Pharmaceuticals (CPIX), from 2018 to 2022: 455 purchases and 0 sales.
Joseph C Galante reported 455 open-market purchases and 0 sales here, 2018 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.